587 related articles for article (PubMed ID: 34503128)
1. Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response.
Rickard BP; Conrad C; Sorrin AJ; Ruhi MK; Reader JC; Huang SA; Franco W; Scarcelli G; Polacheck WJ; Roque DM; Del Carmen MG; Huang HC; Demirci U; Rizvi I
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503128
[TBL] [Abstract][Full Text] [Related]
2. Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.
Rizvi I; Gurkan UA; Tasoglu S; Alagic N; Celli JP; Mensah LB; Mai Z; Demirci U; Hasan T
Proc Natl Acad Sci U S A; 2013 May; 110(22):E1974-83. PubMed ID: 23645635
[TBL] [Abstract][Full Text] [Related]
3. Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress.
Nath S; Pigula M; Khan AP; Hanna W; Ruhi MK; Dehkordy FM; Pushpavanam K; Rege K; Moore K; Tsujita Y; Conrad C; Inci F; Carmen MGD; Franco W; Celli JP; Demirci U; Hasan T; Huang HC; Rizvi I
J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32231055
[TBL] [Abstract][Full Text] [Related]
4. Immune Tumor Microenvironment in Ovarian Cancer Ascites.
Almeida-Nunes DL; Mendes-Frias A; Silvestre R; Dinis-Oliveira RJ; Ricardo S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142615
[TBL] [Abstract][Full Text] [Related]
5. Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components.
Uno K; Iyoshi S; Yoshihara M; Kitami K; Mogi K; Fujimoto H; Sugiyama M; Koya Y; Yamakita Y; Nawa A; Kanayama T; Tomita H; Enomoto A; Kajiyama H
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457198
[TBL] [Abstract][Full Text] [Related]
6. Friend and foe: the regulation network of ascites components in ovarian cancer progression.
Geng Z; Pan X; Xu J; Jia X
J Cell Commun Signal; 2023 Sep; 17(3):391-407. PubMed ID: 36227507
[TBL] [Abstract][Full Text] [Related]
7. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.
Ahmed N; Stenvers KL
Front Oncol; 2013 Sep; 3():256. PubMed ID: 24093089
[TBL] [Abstract][Full Text] [Related]
8. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.
Kim S; Kim B; Song YS
Cancer Sci; 2016 Sep; 107(9):1173-8. PubMed ID: 27297561
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer.
Li Y; Wang W; Wang D; Zhang L; Wang X; He J; Cao L; Li K; Xie H
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553542
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-related oxidative stress contributes to ovarian cancer-promoting activity of mesothelial cells subjected to malignant ascites.
Pakuła M; Mikuła-Pietrasik J; Stryczyński Ł; Uruski P; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
Int J Biochem Cell Biol; 2018 May; 98():82-88. PubMed ID: 29550585
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-Proteasome Axis, Especially Ubiquitin-Specific Protease-17 (
Yildirim N; Kocal GC; Isik Z; Saatli B; Saygili U; Uysal T; Ulukus C; Koyuncuoglu M; Ellidokuz H; Basbinar Y
Reprod Sci; 2019 Jun; 26(6):794-805. PubMed ID: 30198418
[TBL] [Abstract][Full Text] [Related]
12. GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment.
Worley BL; Kim YS; Mardini J; Zaman R; Leon KE; Vallur PG; Nduwumwami A; Warrick JI; Timmins PF; Kesterson JP; Phaëton R; Lee NY; Walter V; Endres L; Mythreye K; Aird KM; Hempel N
Redox Biol; 2019 Jul; 25():101051. PubMed ID: 30509602
[TBL] [Abstract][Full Text] [Related]
13. Ascites Volumes and the Ovarian Cancer Microenvironment.
Penet MF; Krishnamachary B; Wildes FB; Mironchik Y; Hung CF; Wu TC; Bhujwalla ZM
Front Oncol; 2018; 8():595. PubMed ID: 30619738
[TBL] [Abstract][Full Text] [Related]
14. Omentum-on-a-chip: A multicellular, vascularized microfluidic model of the human peritoneum for the study of ovarian cancer metastases.
Ibrahim LI; Hajal C; Offeddu GS; Gillrie MR; Kamm RD
Biomaterials; 2022 Sep; 288():121728. PubMed ID: 35995621
[TBL] [Abstract][Full Text] [Related]
15. Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.
Monavarian M; Elhaw AT; Tang PW; Javed Z; Shonibare Z; Scalise CB; Arend R; Jolly MK; Sewell-Loftin MK; Hempel N; Mythreye K
Semin Cancer Biol; 2022 Nov; 86(Pt 2):709-719. PubMed ID: 35259492
[TBL] [Abstract][Full Text] [Related]
16. The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.
Ritch SJ; Telleria CM
Front Endocrinol (Lausanne); 2022; 13():886533. PubMed ID: 35574025
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
[TBL] [Abstract][Full Text] [Related]
18. The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells.
Pakuła M; Mikuła-Pietrasik J; Witucka A; Kostka-Jeziorny K; Uruski P; Moszyński R; Naumowicz E; Sajdak S; Tykarski A; Książek K
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609691
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
